“Covid-19 Management and Clinical Course in the Era of Population Immunity: Challenges for Immunocompromised Individuals”

https://pubmed.ncbi.nlm.nih.gov/38114838

The clinical course and management of COVID-19 have significantly changed in the era of widespread population immunity, with decreased overall risk of severe disease and the availability of evidence-based treatments, but some individuals, particularly those with immunocompromising conditions, remain at risk for severe outcomes.